DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/wdbt2z/partial_seizure) has announced the addition of the "Partial Seizure - Pipeline Review, H1 2013" report to their offering.
'Partial Seizure - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Partial Seizure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Partial Seizure.
Scope
- A snapshot of the global therapeutic scenario for Partial Seizure.
- A review of the Partial Seizure products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Partial Seizure pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Companies Involved in Partial Seizure Therapeutics Development
- Valeant Pharmaceuticals International
- Novartis AG
- Eisai Co., Ltd.
- Pfizer Inc.
- UCB Group
- Catalyst Pharmaceutical Partners, Inc.
- Upsher-Smith Laboratories, Inc.
- Ache Laboratorios Farmaceuticos S/A
- Marinus Pharmaceuticals, Inc.
- Bial - Portela & Ca, S.A.
Drug Profiles
- lacosamide
- lacosamide
- brivaracetam
- perampanel
- perampanel
- zonisamide
- carisbamate
- carisbamate
- levetiracetam
- levetiracetam
- YKP-3089
- CPP-115
- BGG-492
- topiramate ER
- ganaxolone
- ezogabine
- eslicarbazepine acetate
- levetiracetam
- pregabalin CR
- Remegal
For more information visit http://www.researchandmarkets.com/research/wdbt2z/partial_seizure
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

